Market Access
NICE technology appraisals

Who delays NICE technology appraisals anyway?

Leela Barham looks at the speediness of NICE’s technology appraisals and ongoing efforts to hit the target of NICE publishing final guidance within 90 days of marketing authorisation.

Digital
open-source data

Transforming clinical trials with open-source tech

Clinical trials historically struggled with several key inefficiencies, many of which became painfully apparent during the COVID-19 pandemic, such as the traditional paper-based, manual rev

Sales & Marketing

Sales & Marketing
Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

Digital

Digital
lady pointing at a number of data points
Sponsored

Solution Spotlight: Medscape AI

Medscape AI introduces a global, medical-grade AI search tool exclusively curated from the world’s largest body of clinically vetted content.

Market Access

Editor's Picks

  1. Gilead strikes again, penning $5bn deal to buy Tubulis
  2. US judge blocks bid to curb abortion pill access
  3. Kennedy changes vaccine panel charter after legal setback
  4. Jeito closes 'record' $1.2bn Europe-focused biopharma fund
  5. Boehringer transfers schizophrenia DTx selling rights to Click

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more